GlassScriptPhysician profile
Michael R Alexander
NPI 1467440842
$11,083.79
in general payments reported to CMS, 2019-2025
47 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,374 · 2020: $915 · 2021: $1,731 · 2022: $1,436 · 2023: $1,876 · 2024: $1,960 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,619 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,618.54 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,381.99 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $1,369.42 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $648.43 | 2019-2025 | |
| Abbvie INC. | $608.82 | 2021-2025 | |
| Glaxosmithkline, LLC. | $588.36 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $566.87 | 2019-2025 | Jardiance, Synjardy, Trijardy Xr |
| Lilly USA, LLC | $519.63 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $484.96 | 2019-2025 | Otezla, Repatha, Evenity |
| Antares Pharma, INC. | $357.56 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $327.32 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $323.84 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Almatica Pharma LLC | $225.53 | 2021-2023 | Loreev Xr, Sertraline Hcl |
| Allergan, INC. | $225.03 | 2019-2020 | |
| Inari Medical, INC. | $220.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $217.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.